Fig. 1 · Structure

Documents & Downloads

Glycitein

Cat. No. A12064 CAS 40957-83-3
Glycitein is an O-methylated isoflavone which accounts for 5-10% of the total isoflavones in soy food products.

In Stock

Publications for Glycitein

2 publications citing this product

  1. Azuma T, .et al. , Environ Sci Pollut Res Int, 2017, Aug;24(23):19021-19030 PMID: 28660504
  2. Azuma T, .et al. , Sci Total Environ, 2016, Apr 1;548-549:189-197 PMID: 26802347

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Glycitein competed with radiolabeled estradiol for human ERα and ERβ in a cell-extract binding assay, with greater apparent affinity for ERβ. These results support estrogen-receptor binding under the tested conditions. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cellular Effect

Cell Line Activity Value Description Reference
Melan-a IC50 > 500 μM Inhibition of melanin formation in mouse Melan-a cells after 5 days by ELISA [PMID: 20022495]

Glycitein Research Summary

This section summarizes 2 in vitro studies of Glycitein from 1 published reference. In vitro models include human ERα- or ERβ-containing cell extracts; Saccharomyces cerevisiae reporter cells expressing human ERα or ERβ.

Glycitein In Vitro Studies

In yeast expressing human ERα or ERβ, glycitein induced receptor-dependent β-galactosidase activity at higher concentrations and with a smaller response than estradiol in the tested series. This supports weak estrogenic activity in this reporter model. [1]

Competition for human estrogen receptors

Biochemical assay · Human ERα- or ERβ-containing cell extracts [1]

Glycitein displaced radiolabeled estradiol, with stronger apparent binding to ERβ than ERα and weaker binding than estradiol. This is a binding assay, not a treatment-efficacy test.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Displacement of receptor-bound [3H]-17β-estradiolQualitative concentration-response Binding observed at both subtypes; greater apparent affinity for ERβ.[1]

Literature-Reported Treatment Conditions

Treatment concentration
Variable competitor concentrations, plotted as fold excess of estradiol in Figure 5A; 2.5 pmol radiolabeled estradiol in 250 μL assay mixture.
Exposure duration
16 h
Method
Cell-free competition assay at 0 °C.
Co-treatment
Glycitein tested as a competitor of radiolabeled estradiol, not a drug combination.
Reported limits
Vehicle not specified in the competition subsection; no fitted glycitein IC50 or Ki supplied. Receptor-free extract and testosterone specificity results are described as data not shown.
Methods and source locations

Compound reported in the paper: Glycitein; Compound label in the paper: GLE; filled triangles in Figure 5

Evidence concerns the paper’s isolated glycitein; no validation of an Adooq lot.

Figure 1, p. 352; Competition Assay of Isoflavone, p. 352; specificity controls, p. 353; Figure 5A and Results, p. 354

Displacement of receptor-bound [3H]-17β-estradiol: Radioligand competition with charcoal separation and scintillation counting. — Figure 5A, p. 354; Competition Assay of Isoflavone, p. 352; specificity controls, p. 353

Human estrogen receptor reporter response in yeast

Cell-based study · Saccharomyces cerevisiae reporter cells expressing human ERα or ERβ [1]

Glycitein induced a weaker reporter response than estradiol, at higher concentrations in the plotted series. Binding and reporter activity are distinct endpoints.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Estrogen receptor-dependent β-galactosidase inductionQualitative concentration-response Activity induced at the higher end of the glycitein concentration series; response below that of estradiol.[1]

Literature-Reported Treatment Conditions

Treatment concentration
Concentration-response series plotted in M in Figure 5B; individual numerical doses were not tabulated or digitized.
Method
Human ERα/ERβ-dependent yeast β-galactosidase reporter assay.
Co-treatment
Glycitein alone; estradiol served as the reference ligand.
Reported limits
Ligand-exposure duration, vehicle and replicate count are not specified in the reporter subsection or Figure 5 caption. The method refers to an earlier publication. No fitted glycitein EC50 is supplied.
Methods and source locations

Compound reported in the paper: Glycitein; Compound label in the paper: GLE; filled triangles in Figure 5

Evidence concerns the paper’s isolated glycitein; no validation of an Adooq lot.

Estrogen Receptor-Dependent Transcriptional Expression Induced by Isoflavone, p. 352; Figure 3 caption and vector control, p. 353; Figure 5B and Results, p. 354

Estrogen receptor-dependent β-galactosidase induction: β-Galactosidase substrate conversion measured as OD415 nm. — Figure 5B and Results, p. 354; Figure 3 caption and vector control, p. 353

Specifications

Manufacturer Adooq Bioscience
CAS Number 40957-83-3
Formula C16H12O5
Molecular Weight 284.3
SMILES
COC1=C(C=C2C(=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 48 mg/mL (168.86 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Glycitein Research References

  1. [1] Keiko Morito, Toshiharu Hirose, Junei Kinjo, et al. Interaction of Phytoestrogens with Estrogen Receptors α and β Biological and Pharmaceutical Bulletin (2001). PMID: 11305594 DOI: 10.1248/bpb.24.351 Source material

Publications

2 publications citing this product

  1. Azuma T, .et al. , Environ Sci Pollut Res Int, 2017, Aug;24(23):19021-19030 PMID: 28660504
  2. Azuma T, .et al. , Sci Total Environ, 2016, Apr 1;548-549:189-197 PMID: 26802347

Added to your cart

View Cart Checkout
Loading...